相似文献
1
BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation.
Oncoimmunology. 2013 Sep 1;2(9):e25853. doi: 10.4161/onci.25853. Epub 2013 Jul 29.
2
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Blood. 2013 Aug 8;122(6):922-31. doi: 10.1182/blood-2012-11-464685. Epub 2013 May 21.
3
The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.
Immun Inflamm Dis. 2021 Mar;9(1):274-287. doi: 10.1002/iid3.390. Epub 2020 Dec 17.
4
Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis.
Cell Mol Immunol. 2012 May;9(3):245-54. doi: 10.1038/cmi.2011.50. Epub 2011 Dec 5.
5
Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
Oncotarget. 2017 Jul 11;8(28):45928-45942. doi: 10.18632/oncotarget.17498.
6
The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responses.
Immunity. 2013 Dec 12;39(6):1082-1094. doi: 10.1016/j.immuni.2013.10.017. Epub 2013 Dec 5.
7
Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.
Mol Med. 2001 Oct;7(10):711-22.
8
CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
Eur J Immunol. 2011 Jan;41(1):195-201. doi: 10.1002/eji.201040905. Epub 2010 Dec 3.
9
Expression of B and T lymphocyte attenuator, retinoid-related orphan receptor gamma-isoform-t and interleukin 7 in psoriasis vulgaris.
Australas J Dermatol. 2019 May;60(2):e132-e137. doi: 10.1111/ajd.12965. Epub 2019 Jan 22.
10
B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5121-6. doi: 10.1073/pnas.1222093110. Epub 2013 Mar 11.
引用本文的文献
1
Virtual Evolution of HVEM Segment for Checkpoint Inhibitor Discovery.
Int J Mol Sci. 2021 Jun 21;22(12):6638. doi: 10.3390/ijms22126638.
2
The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.
Immun Inflamm Dis. 2021 Mar;9(1):274-287. doi: 10.1002/iid3.390. Epub 2020 Dec 17.
3
Targeting the interleukin-17 immune axis for cancer immunotherapy.
J Exp Med. 2020 Jan 6;217(1). doi: 10.1084/jem.20190456.
4
BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection.
Front Immunol. 2019 Mar 29;10:617. doi: 10.3389/fimmu.2019.00617. eCollection 2019.
5
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.
Immunotherapy. 2015;7(11):1169-86. doi: 10.2217/imt.15.78. Epub 2015 Nov 16.
本文引用的文献
1
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Blood. 2013 Aug 8;122(6):922-31. doi: 10.1182/blood-2012-11-464685. Epub 2013 May 21.
2
High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
Leukemia. 2012 Mar;26(3):559-62. doi: 10.1038/leu.2011.266. Epub 2011 Sep 23.
3
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
Eur J Immunol. 2011 Feb;41(2):345-55. doi: 10.1002/eji.201040959. Epub 2011 Jan 11.
4
PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
Int Immunol. 2010 Dec;22(12):915-25. doi: 10.1093/intimm/dxq446. Epub 2010 Nov 3.
5
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
Cancer Res. 2010 Nov 15;70(22):9166-74. doi: 10.1158/0008-5472.CAN-10-2460. Epub 2010 Sep 30.
6
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.
Blood. 2009 May 14;113(20):4875-84. doi: 10.1182/blood-2008-08-172296. Epub 2009 Mar 10.
7
ICOS contributes to T cell expansion in CTLA-4 deficient mice.
J Immunol. 2005 Jul 1;175(1):182-8. doi: 10.4049/jimmunol.175.1.182.
8
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
Nat Immunol. 2005 Jan;6(1):90-8. doi: 10.1038/ni1144. Epub 2004 Nov 28.
9
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
Nat Immunol. 2003 Jul;4(7):670-9. doi: 10.1038/ni944. Epub 2003 Jun 8.
10
CTLA-4-Mediated inhibition of early events of T cell proliferation.
J Immunol. 1999 May 15;162(10):5813-20.
Zotero 插件